These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2377983)

  • 1. Prophylaxis of oxalate urolithiasis with alkaline citrates.
    Frang D; Berényi M; Szebeni R
    Ther Hung; 1990; 38(2):64-70. PubMed ID: 2377983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oxalate stone prophylaxis by alkalinizing therapy (author's transl)].
    Butz M
    Urologe A; 1982 May; 21(3):142-6. PubMed ID: 7048691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution of uric acid-urate stones and prophylaxis of recurrency with Magurlit.
    Baán L; Jancsó T; Ficsor E; Makáry G; Walter G
    Ther Hung; 1983; 31(3):127-8. PubMed ID: 6571187
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical studies of Magurlit granulates].
    Frang D; Verebélyi A; Nagy Z
    Acta Chir Acad Sci Hung; 1978; 19(4):363-72. PubMed ID: 757918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined administration of calcium and citrate reduces urinary oxalate excretion].
    Ito H
    Hinyokika Kiyo; 1991 Oct; 37(10):1107-10. PubMed ID: 1755399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year observations with Magurlit, a stone-dissolving granulate.
    Baranyai E; Kis E; Szebeni R
    Ther Hung; 1980; 28(4):177-9. PubMed ID: 7209851
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Granulated potassium citrate in the prevention of calcium oxalate lithiasis].
    Campoy Martínez P; Arrabal Martín M; Quintero Rodríguez R; Espinosa Olmedo FJ; Castillo Gómez J; García Pérez M
    Actas Urol Esp; 1994 Feb; 18(2):101-5. PubMed ID: 7976691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary citrate excretion in children with calcium urolithiasis].
    Sikora P; Bieniaś B; Majewski M; Borzecka H; Wawrzyszuk M; Zajaczkowska M
    Przegl Lek; 2006; 63 Suppl 3():134-6. PubMed ID: 16898511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of calcium oxalate urolithiasis in experiment and its inhibition by pyridoxine and magnesium.
    Krídl J; Zvara V; Revúsová V; Ondrus B
    Czech Med; 1986; 9(3):124-9. PubMed ID: 3095070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the effects of pyruvate and CG-120 in preventing experimental oxalate urolithiasis in rats.
    Ogawa Y; Yamaguchi K; Tanaka T; Morozumi M
    Hinyokika Kiyo; 1986 Sep; 32(9):1341-7. PubMed ID: 3812152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reduction of urinary oxalate excretion by administration of calcium and citrate].
    Ito H; Yamaguchi K; Nishikawa Y; Kotake T
    Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1417-21. PubMed ID: 2601215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifteen-year experience with Magurlit in the treatment of patients with uric acid calculi.
    Frang D
    Ther Hung; 1986; 34(1):26-34. PubMed ID: 3447298
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis.
    Hosking DH; Wilson JW; Liedtke RR; Smith LH; Wilson DM
    J Lab Clin Med; 1985 Dec; 106(6):682-9. PubMed ID: 4067380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.